Literature DB >> 1804042

Immunoadjuvant properties of chitosan.

J Marcinkiewicz1, A Polewska, J Knapczyk.   

Abstract

Adjuvant activity of water insoluble chitosan suspension was examined in CBA mice. Among different types of immune reaction only T-dependent humoral response against SRBC was enhanced by injection of chitosan. The optimal conditions of administration of both agents (antigen-SRBC, adjuvant-chitosan) was established.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1804042

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN： 0004-069X            Impact factor:   4.291


  8 in total

1.  Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.

Authors:  David A Zaharoff; Connie J Rogers; Kenneth W Hance; Jeffrey Schlom; John W Greiner
Journal:  Vaccine       Date:  2006-12-04       Impact factor: 3.641

2.  Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence.

Authors:  Yali Qin; Marisa Banasik; SoonJeung Kim; Adam Penn-Nicholson; Habtom H Habte; Celia LaBranche; David C Montefiori; Chong Wang; Michael W Cho
Journal:  Virology       Date:  2014-08       Impact factor: 3.616

3.  Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.

Authors:  Caitlin D Lemke; Jessica B Graham; Sean M Geary; Gideon Zamba; David M Lubaroff; Aliasger K Salem
Journal:  Mol Pharm       Date:  2011-08-09       Impact factor: 4.939

4.  Glycated chitosan as a new non-toxic immunological stimulant.

Authors:  Sheng Song; Feifan Zhou; Robert E Nordquist; Raoul Carubelli; Hong Liu; Wei R Chen
Journal:  Immunopharmacol Immunotoxicol       Date:  2009-06       Impact factor: 2.730

5.  Modulatory effects of chitosan adipate on the T and B lymphocyte subsets in mice.

Authors:  Bozena Obmińska-Mrukowicz; Marianna Szczypka; Bartosz Gaweda
Journal:  J Vet Sci       Date:  2006-06       Impact factor: 1.672

6.  Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection.

Authors:  Bunsoon Choi; Do-Hyun Jo; A K M Mostafa Anower; S M Shamsul Islam; Seonghyang Sohn
Journal:  Mediators Inflamm       Date:  2016-12-21       Impact factor: 4.711

7.  Efficacy of instillation of MB49 cells and thermoreversible polymeric gel in urothelial bladder carcinoma immunization.

Authors:  Jhonne Pedro Pedott Santana; Priscyla Daniely Marcato; Tais Nader Chrysostomo Massaro; Naiane Lima Godoy; Fernanda de Freitas Anibal; Ricardo Carneiro Borra
Journal:  Lab Anim Res       Date:  2022-05-05

Review 8.  Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.

Authors:  Xiaosong Li; Min Min; Nan Du; Ying Gu; Tomas Hode; Mark Naylor; Dianjun Chen; Robert E Nordquist; Wei R Chen
Journal:  Clin Dev Immunol       Date:  2013-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.